Provided by Tiger Fintech (Singapore) Pte. Ltd.

AbbVie

193.34
-1.7600-0.90%
Post-market: 193.10-0.2400-0.12%19:57 EDT
Volume:5.82M
Turnover:1.13B
Market Cap:342.01B
PE:82.63
High:195.82
Open:192.88
Low:189.80
Close:195.10
Loading ...

Abbvie Q1 Rinvoq Net Revenue $1.72 Bln VS Ibes Estimate $1.59 Bln

THOMSON REUTERS
·
25 Apr

Abbvie Q1 Skyrizi Net Revenue $3.43 Bln VS Ibes Estimate $3.15 Bln

THOMSON REUTERS
·
25 Apr

Abbvie: Well Positioned for the Long Term

THOMSON REUTERS
·
25 Apr

Abbvie Reports First-Quarter 2025 Financial Results

THOMSON REUTERS
·
25 Apr

Abbvie Q1 Adjusted EPS USD 2.46 VS. Ibes Estimate USD 2.38

THOMSON REUTERS
·
25 Apr

AbbVie Reports First-Quarter 2025 Financial Results

PR Newswire
·
25 Apr

A cruel summer looms, but here's why JPMorgan still expects a higher S&P 500 finish this year

Dow Jones
·
25 Apr

LIVE MARKETS-Focus on earnings while US and China quibble

Reuters
·
25 Apr

What to Watch in the Day Ahead - Friday, April 25

Reuters
·
25 Apr

AbbVie Submits Biologics License Application to FDA for Glabellar Lines Treatment

MT Newswires Live
·
24 Apr

BRIEF-AbbVie Submits Biologics License Application To U.S. FDA For Trenibotulinumtoxine (TrenibotE) For The Treatment Of Glabellar Lines

Reuters
·
24 Apr

Abbvie Submits Biologics License Application to U.S. FDA for Trenibotulinumtoxine (Trenibote) for the Treatment of Glabellar Lines

THOMSON REUTERS
·
24 Apr

AbbVie (ABBV) Reports Earnings Tomorrow: What To Expect

StockStory
·
24 Apr

Buy Stock in These Healthcare Leaders as Q1 Earnings Approach? ABBV, HCA

Zacks
·
24 Apr

AbbVie Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
24 Apr

Why AbbVie Inc. (ABBV) is Among the Best Stocks That Will Always Grow

Insider Monkey
·
23 Apr

The Zacks Analyst Blog Highlights Gilead Sciences, Bristol Myers, Merck, AbbVie and Sanofi

Zacks
·
23 Apr

Buy, Sell or Hold ABBV Stock? Key Tips Ahead of Q1 Earnings

Zacks
·
23 Apr

AbbVie’s Strategic Acquisitions and Strong Financial Outlook Justify Buy Rating

TIPRANKS
·
23 Apr

Eli Lilly, Vertex, AbbVie and More Pharma Stocks to Own as Tariffs Loom -- Barrons.com

Dow Jones
·
22 Apr